These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 8006593

  • 1. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T.
    J Exp Med; 1994 Jul 01; 180(1):35-42. PubMed ID: 8006593
    [Abstract] [Full Text] [Related]

  • 2. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T.
    J Exp Med; 1993 Aug 01; 178(2):489-95. PubMed ID: 8340755
    [Abstract] [Full Text] [Related]

  • 3. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes.
    Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Büschenfelde KH, Boon T.
    Eur J Immunol; 1994 Mar 01; 24(3):759-64. PubMed ID: 8125142
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.
    Anichini A, Mortarini R, Maccalli C, Squarcina P, Fleischhauer K, Mascheroni L, Parmiani G.
    J Immunol; 1996 Jan 01; 156(1):208-17. PubMed ID: 8598464
    [Abstract] [Full Text] [Related]

  • 5. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.
    Schneider J, Brichard V, Boon T, Meyer zum Büschenfelde KH, Wölfel T.
    Int J Cancer; 1998 Jan 30; 75(3):451-8. PubMed ID: 9455808
    [Abstract] [Full Text] [Related]

  • 6. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 7. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.
    Spagnoli GC, Schaefer C, Willimann TE, Kocher T, Amoroso A, Juretic A, Zuber M, Luscher U, Harder F, Heberer M.
    Int J Cancer; 1995 Oct 20; 64(5):309-15. PubMed ID: 7591302
    [Abstract] [Full Text] [Related]

  • 8. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.
    Slingluff CL, Colella TA, Thompson L, Graham DD, Skipper JC, Caldwell J, Brinckerhoff L, Kittlesen DJ, Deacon DH, Oei C, Harthun NL, Huczko EL, Hunt DF, Darrow TL, Engelhard VH.
    Cancer Immunol Immunother; 2000 Mar 20; 48(12):661-72. PubMed ID: 10752474
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
    Sensi M, Traversari C, Radrizzani M, Salvi S, Maccalli C, Mortarini R, Rivoltini L, Farina C, Nicolini G, Wölfel T.
    Proc Natl Acad Sci U S A; 1995 Jun 06; 92(12):5674-8. PubMed ID: 7777568
    [Abstract] [Full Text] [Related]

  • 10. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C, Davodeau F, Guilloux Y, Bignon JD, Semana G, Breathnach R, Jotereau F.
    Eur J Immunol; 1993 Jan 06; 23(1):141-6. PubMed ID: 8419164
    [Abstract] [Full Text] [Related]

  • 11. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.
    Brichard VG, Herman J, Van Pel A, Wildmann C, Gaugler B, Wölfel T, Boon T, Lethé B.
    Eur J Immunol; 1996 Jan 06; 26(1):224-30. PubMed ID: 8566071
    [Abstract] [Full Text] [Related]

  • 12. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Sakaguchi K, Appella E, Rosenberg SA.
    J Immunol; 1998 Dec 15; 161(12):6985-92. PubMed ID: 9862734
    [Abstract] [Full Text] [Related]

  • 13. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
    Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethé B, Jotereau F, Boon T.
    J Exp Med; 1996 Mar 01; 183(3):1173-83. PubMed ID: 8642259
    [Abstract] [Full Text] [Related]

  • 14. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A, Maccalli C, Mortarini R, Salvi S, Mazzocchi A, Squarcina P, Herlyn M, Parmiani G.
    J Exp Med; 1993 Apr 01; 177(4):989-98. PubMed ID: 8459226
    [Abstract] [Full Text] [Related]

  • 15. Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2.
    Ma W, Germeau C, Vigneron N, Maernoudt AS, Morel S, Boon T, Coulie PG, Van den Eynde BJ.
    Int J Cancer; 2004 May 01; 109(5):698-702. PubMed ID: 14999777
    [Abstract] [Full Text] [Related]

  • 16. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
    Zarour H, De Smet C, Lehmann F, Marchand M, Lethé B, Romero P, Boon T, Renauld JC.
    J Invest Dermatol; 1996 Jul 01; 107(1):63-7. PubMed ID: 8752841
    [Abstract] [Full Text] [Related]

  • 17. Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
    Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T.
    J Immunother Emphasis Tumor Immunol; 1993 Aug 01; 14(2):104-9. PubMed ID: 8280701
    [Abstract] [Full Text] [Related]

  • 18. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
    Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH.
    Int J Cancer; 1994 Dec 15; 59(6):837-42. PubMed ID: 7989126
    [Abstract] [Full Text] [Related]

  • 19. Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.
    Riley JP, Rosenberg SA, Parkhurst MR.
    J Immunother; 2001 Dec 15; 24(3):212-20. PubMed ID: 11394498
    [Abstract] [Full Text] [Related]

  • 20. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
    Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG.
    Cancer Res; 2002 Oct 01; 62(19):5510-6. PubMed ID: 12359761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.